- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: AK104 plus Carboplatin and Pemetrexed
Total 6988 results
-
Sun Yat-sen UniversityUnknown
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedPemetrexed Disodium and Carboplatin in Treating Patients With Extensive-Stage Small Cell Lung CancerLung CancerUnited States
-
Baylor College of MedicineDuke Cancer InstituteNot yet recruitingMesotheliomaUnited States
-
Yonsei UniversityRecruitingBreast CancerKorea, Republic of
-
Suzhou Puhe Pharmaceutical Technology Co., LTDNot yet recruitingAdvanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)China
-
Sichuan UniversityChia Tai Tianqing Pharmaceutical Group Co., Ltd.CompletedNon-squamous Non-small-cell Lung Cancer | AnlotinibChina
-
Li Zhang, MDRecruitingCarcinoma, Non-Small-Cell LungChina
-
Eli Lilly and CompanyTerminatedSmall Cell Lung CancerItaly, Poland, United Kingdom, Spain
-
Northwestern UniversityNational Cancer Institute (NCI)WithdrawnAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Metastatic Triple-Negative Breast Carcinoma | Breast Inflammatory CarcinomaUnited States
-
Peking UniversityNot yet recruitingMSI-H/dMMR Gastric Carcinoma and Colorectal Cancer
-
AkesoAkesobio Australia Pty LtdCompletedMetastatic Cervical Cancer | Recurrent Cervical CancerUnited States, Australia, New Zealand
-
AkesoAkeso Pharmaceuticals, Inc.TerminatedMSI-H/dMMR Solid TumorChina
-
AkesoAkeso Pharmaceuticals, Inc.CompletedNasopharyngeal CarcinomaChina
-
Cancer Institute and Hospital, Chinese Academy...UnknownAdenocarcinoma | NSCLC | Squamous Cell Carcinoma
-
CrystalGenomics, Inc.RecruitingNon Squamous Non Small Cell Lung CancerKorea, Republic of
-
AkesoCompletedHealthy Male SubjectsChina
-
Shanghai Pulmonary Hospital, Shanghai, ChinaRecruitingTreatment | Histological Type of Neoplasm | Lung Adenocarcinoma, Stage I | Chemotherapy, AdjuvantChina
-
Yonsei UniversityNot yet recruitingNon Small Cell Lung CancerKorea, Republic of
-
AstraZenecaParexelActive, not recruitingNon-small Cell Lung CancerItaly, Spain, United States, China, Germany, Israel
-
Innovent Biologics (Suzhou) Co. Ltd.Not yet recruitingNon-squamous Non-small-cell Lung CancerChina
-
Beijing Cancer Prevention & Treatment SocietyCancer Institute and Hospital, Chinese Academy of Medical SciencesRecruitingNon Small Cell Lung CancerChina
-
ORIC PharmaceuticalsRecruitingSolid TumorsKorea, Republic of, United States, Australia, Taiwan, Poland, Canada, Hong Kong, United Kingdom
-
Sun Yat-sen UniversityGeneCast Biotechnology Co., Ltd.; Allist Pharmaceuticals, Inc.RecruitingNon-small Cell Lung CancerChina
-
Jiangsu Hansoh Pharmaceutical Co., Ltd.Not yet recruiting
-
Eli Lilly and CompanyCompletedNon-Small-Cell Lung CancerUnited States, India
-
Yonsei UniversityNot yet recruitingNon-small Cell Lung CancerKorea, Republic of
-
Hutchison Medipharma LimitedRecruitingNon-small Cell Lung CancerChina
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.UnknownAdvanced Non-squamous Cell Non-small Cell Lung CancerChina
-
NextCure, Inc.WithdrawnNon-Small Cell Lung Cancer | Advanced or Metastatic Solid Tumors
-
Avistone Biotechnology Co., Ltd.Not yet recruiting
-
AkesoRecruiting
-
Amsterdam UMC, location VUmcRecruitingNon-Small Cell Lung CancerNetherlands
-
Sun Yat-sen UniversityCompletedBrain Metastases | NSCLC Stage IV | PD-1 AntibodyChina
-
Innovent Biologics (Suzhou) Co. Ltd.RecruitingAdvanced Non-Small Cell Lung CancerChina
-
West China HospitalJiangsu HengRui Medicine Co., Ltd.UnknownApatinib Combine With Platinum-Based Doublet Chemotherapy for First-line Treatment of Advanced NSCLCLung Cancer | Non Small Cell Lung Cancer | Apatinib | Combination ChemotherapyChina
-
AstraZenecaActive, not recruitingNon Small Cell Lung Carcinoma NSCLCDenmark, United Kingdom, United States, Poland, Brazil, India, Japan, Mexico, Peru, Russian Federation, Turkey, China, Malaysia, Hong Kong, Korea, Republic of, Chile, Israel, Ukraine, Portugal, Greece, Bulgaria, Philippines, Sweden, A... and more
-
AstraZenecaActive, not recruitingNon Small Cell Lung Carcinoma NSCLCPoland, Taiwan, Thailand, Vietnam, United States, Korea, Republic of, Hungary, Russian Federation, Turkey, China, Australia, Netherlands
-
Yonsei UniversityNot yet recruitingNon-small Cell Lung CancerKorea, Republic of
-
Taizhou Hanzhong biomedical co. LTDRecruitingNonsquamous Non-small Cell Lung CancerChina
-
Shanghai Chest HospitalCompletedLung Adenocarcinoma | EGFR Activating Mutation
-
Jonsson Comprehensive Cancer CenterTetraLogic Pharmaceuticals; California Institute for Regenerative Medicine... and other collaboratorsWithdrawnRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Primary Peritoneal High Grade Serous Adenocarcinoma | High Grade Ovarian Serous Adenocarcinoma | High Grade Fallopian Tube Serous AdenocarcinomaUnited States
-
Alliance for Clinical Trials in OncologyBristol-Myers Squibb; National Cancer Institute (NCI); Eli Lilly and CompanyCompleted
-
AstraZenecaParexelRecruitingNon-small Cell Lung CancerHungary, United States, Italy, Belgium, Spain, France, Korea, Republic of, Taiwan, Turkey, Ireland, Portugal, Canada
-
Masonic Cancer Center, University of MinnesotaRecruitingLung Cancer | Adenocarcinoma of LungUnited States
-
Northwestern UniversityNational Cancer Institute (NCI)Completed
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)WithdrawnRecurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer
-
Eli Lilly and CompanyCompletedNon-Small Cell Lung CancerTaiwan, Korea, Republic of, Brazil, China, Australia, Mexico
-
Sichuan Cancer Hospital and Research InstituteChia Tai Tianqing Pharmaceutical Group Co., Ltd.UnknownLung Cancer MetastaticChina
-
AkesoAkeso Pharmaceuticals, Inc.TerminatedPeripheral T-cell LymphomaChina